FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/29/2026
Back to search
Official data from USPTO
UMZOON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 44
Filing date
02/06/2024
Registration date
06/17/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/17/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
CH
Examiner
DUBIN, DAVID I
Law office
L70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Novartis AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of dermatological diseases; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in the treatment of hematology diseases; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in the treatment of ophthalmology diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Class 44
Collection and preservation of human blood; Collection and preservation services for tissue and cellscollection and banking of umbilical cord tissue perivascular stem cells; medical diagnostic services; medical treatment services being medical analysis services relating to the treatment of patients; provision of medical information and remote monitoring of medical data for medical diagnosis and medical treatment
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/14/2026
FIMP
FINAL DISPOSITION PROCESSED
01/14/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/10/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/24/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/24/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/17/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/17/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/17/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/29/2025
PUBO
PUBLISHED FOR OPPOSITION
04/29/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/23/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/10/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/10/2025
RFNT
REFUSAL PROCESSED BY IB
01/17/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/02/2025
RFRR
REFUSAL PROCESSED BY MPU
01/02/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/17/2024
CNRT
NON-FINAL ACTION WRITTEN
12/16/2024
DOCK
ASSIGNED TO EXAMINER
08/09/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/13/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/13/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/13/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/13/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/13/2024
MAFR
APPLICATION FILING RECEIPT MAILED
05/10/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/10/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/25/2024
Continuous trademark protection
Get notified about every new filing that threatens UMZOON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.